Search Results | MSF Science Portal

Journal Article

|

Research

Gotham D, Martin M, Barber MJ, Kazounis E, Batts C, et al.

2025-04-23 • PLOS Global Public Health

Clinical trials are considered to be the largest contributor to pharmaceutical development costs. However, public disclosure of the costs of individual clinical trials is rare. Médec...

Conference Material

|

Abstract

Gotham D, Martin M, Barber M, Kazounis E, Batts C, et al.

2024-05-16 • MSF Scientific Day International 2024

INTRODUCTION
Clinical trials are a cornerstone of medical innovation. Nonetheless, little information on the cost of conducting clinical trials is available, especially for clinical ...

Conference Material

|

Slide Presentation

Gotham D, Martin M, Barber M, Kazounis E, Batts C, et al.

2024-05-16 • MSF Scientific Day International 2024

Journal Article

|

Research

Grandesso F, Allan M, Jean-Simon PSJ, Boncy J, Blake A, et al.

2013-10-11 • Epidemiology and Infection

SUMMARY Two community-based density case-control studies were performed to assess risk factors for cholera transmission during inter-peak periods of the ongoing epidemic in two Haitian u...

Journal Article

|

Research

Teicher CL, Alberti KP, Porten K, Elder G, Baron E, et al.

2014-01-15 • Prehospital and Disaster Medicine

INTRODUCTION
During January 2010, a 7.0 magnitude earthquake struck Haiti, resulting in death and destruction for hundreds of thousands of people. This study describes the types of o...

Journal Article

|

Research

Grellety E, Luquero FJ, Mambula C, Adamu HH, Elder G, et al.

2013-05-03 • PLOS One

The Sahel is subject to seasonal hungry periods with increasing rates of malnutrition. In Northern Nigeria, there is no surveillance system and surveys are rare. The objectives were to a...

Journal Article

|

Commentary

Elder K, Saitta B, Ducomble T, Alia M, Close R, et al.

2019-10-28 • Bulletin of the World Health Organization

Vaccination is an effective intervention to reduce disease, disability, death and health inequities worldwide. Over the last two decades, vaccines have become more accessible in low-inco...

Journal Article

|

Commentary

Elder G, Murphy RA, Herard P, Dilworth K, Olson D, et al.

2015-07-01 • Surgery

Journal Article

|

Commentary

Checchi F, Elder G, Schäfer M, Drouhin E, Legros D

2003-07-05 • Lancet

Journal Article

|

Commentary

Perrin C, Athersuch K, Elder G, Martin M, Alsalhani A

2022-04-19 • BMJ Global Health

Two drugs with novel mechanisms of action, the diarylquinoline bedaquiline and the nitroimidazole delamanid—as well as pretomanid from the same class of drugs as delamanid—have recently ...

Journal Article

|

Research

Coldiron ME, Lasry E, Bouhenia M, Das D, Okui P, et al.

2017-05-23 • Malaria Journal

Northern Uganda hosts a large population of refugees from South Sudan, and malaria is one of the major health problems in the area. In 2015, intermittent preventive treatment for malaria...

Journal Article

|

Research

Murphy RA, Okoli O, Essien I, Teicher CL, Elder G, et al.

2016-08-11 • Epidemiology and Infection

The epidemiology of surgical site infections (SSIs) in surgical programmes in sub-Saharan Africa is inadequately described. We reviewed deep and organ-space SSIs occurring within a traum...

Journal Article

|

Research

Gosselin RA, Maldonado A, Elder G

2010-03-01 • World Journal of Surgery

INTRODUCTION: There is a dearth of data on cost-effectiveness of surgical care in resource-poor countries. Doctors Without Borders (Médecins Sans Frontières; MSF) is a nongovernmental or...

Technical Report

|

Policy Brief

Karir V, Bygrave H, Cepuch C, Davis B, Elder G, et al.

2019-09-23

This is a summary of work undertaken between March 2018 and May 2018 in order to increase understanding of accessibility to medicines for major non-communicable diseases (NCDs) among Jor...

Science Portal

Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens

Application of the Médecins Sans Frontières clinical trial transparency policy: cost analysis of TB-PRACTECAL, a multicentre phase 2–3 trial in drug-resistant tuberculosis

Application of the Médecins Sans Frontières clinical trial transparency policy: cost analysis of TB-PRACTECAL, a multicentre phase 2–3 trial in drug-resistant tuberculosis

Risk factors for cholera transmission in Haiti during inter-peak periods: insights to improve current control strategies from two case-control studies

Médecins Sans Frontières experience in orthopedic surgery in post-earthquake Haiti in 2010

Observational bias during nutrition surveillance: results of a mixed longitudinal and cross-sectional data collection system in northern Nigeria

Ensuring access to affordable, timely vaccines in emergencies

Challenging the barriers to accessing surgery in low-resource settings: Lessons learned from burns

Consequences of armed conflict for an ethnic Karen population

Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study

Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned

Multidrug-resistant surgical site infections in a humanitarian surgery project

Comparative cost-effectiveness analysis of two MSF surgical trauma centers

Accessibility to medicines for major non-communicable diseases in Jordan - 2018